Navigation Links
Spherix Phase 2 Trial with D-tagatose Determines Minimum Dose for HbA1c and Triglycerides
Date:12/9/2010

BETHESDA, Md., Dec. 9, 2010 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested (2.5, 5.0, and 7.5 g TID), with the 2.5 and 5.0 g doses producing similar responses to one another, and the 7.5 g dose producing a greater response.

In addition, by the end of the six-month trial, the 7.5 g dose reduced serum triglycerides vs. the 2.5 g dose by -42 mg/dl from a mean of 180 mg/dl in the Evaluable Efficacy (EE) population. The reduction in serum triglycerides became statistically significant in the Intent-To-Treat (ITT) population at three months of treatment (-31 mg/dl, p=0.03) and the reduction essentially held steady at the six-month end-of-study visit (-29 mg/dl).

In the single-blind study designed to establish the minimum dose capable of causing a beneficial effect, three different doses of D-tagatose were administered to patients orally with meals TID. The comparator was the 2.5 g dose. The study was designed with a minimum of 34 patients in each of the three groups for a total of 102 evaluable patients. The primary endpoint for the study was reduction in HbA1c after six months of treatment. In the minimum dose range, D-tagatose produced a -0.3% reduction in HbA1c in the 7.5 g dose group vs. the 2.5 g dose group in the EE population, from a mean randomization HbA1c of 7.4%. The reduction of the 7.5 g dose was 0.2% more than the 2.5 g dose in the ITT population.

Unlike
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
2. Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
3. Spherix Announces Closing of Institutional Investors Purchase of $5.25 Million of Convertible Preferred Stock and Warrants
4. Spherix Announces Statistically Significant Results in Phase 3 Study With D-tagatose in Type 2 Diabetes
5. Spherix Announces Second Quarter 2010 Financial Results
6. Spherix Announces the Closing of $6.3 Million Registered Direct Offering
7. Spherix Announces Results of Annual Shareholders Meeting
8. Spherix Incorporated Announces Annual Shareholders Meeting Date
9. Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development
10. Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
11. Spherix Reports Second Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014 James Sherley says he ... adult tissue stem cell technology since his days as a ... Philadelphia in the late 1990’s. Sherley founded the ASCTC ... company holds all the intellectual property developed in Sherley’s research ... the Massachusetts Institute of Technology (MIT), and more recently as ...
(Date:10/30/2014)... Khaimah, UAE (PRWEB) October 30, 2014 Grace ... of Dr. James A. Manganello, Chairman of the Board, to ... The Bahamas. The appointment was made by the Ministry ... on September 24th, 2014. , More than a ... and Research Bill , Prime Minister Perry Christie said the ...
(Date:10/30/2014)... in the development of quantum technologies has been proposed ... published today (28 October) in Nature Communications , ... a new type of flexibly designed microscopic trap for ... and specialised superfast computers, often depend on harnessing the ... these tiny particles are hugely problematic because of the ...
(Date:10/27/2014)... , October 27, 2014 ... right to produce, exhibit and sell its artificial ... to impeach their patent.      (Photo: ... four years of fighting, the definitive judgement has ... and produces innovative and accessible hi-tech prostheses with ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2
... PharmaNet Development Group, Inc., a leading provider of clinical development services to ... participation at several international professional meetings during the month of June. ... Drug Information Association (DIA) Annual Meeting, ... ...
... ... The use of codon optimization in gene synthesis has long been ... been awarded two US patents covering the technology. DNA2.0,s approach goes beyond ... gene optimization. The algorithm associated with this patent has been proven to ...
... the momentum of their previous events, the Stem Cell ... Stem Cell Awareness Rally in Denver, Colorado on June ... Florida, drew past and prospective patients, news media, U.S. ... public interested in learning more about stem cell treatment. ...
Cached Biology Technology:PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 2DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches 3Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 2Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009 3
(Date:10/28/2014)... Europe and China have published a paper in the ... that reveals important details about key transitions in the ... and exotic algae, mosses, ferns, trees and flowers growing ... we eat and the ornamental plants adorning our homes, ... years of history., "Our study generated DNA sequences from ...
(Date:10/28/2014)... moving activity in a novel environment are linked ... to an experimental study completed at the University ... Fisheries Research Institute. The study used novel, long-term ... angling trials to analyse if behaviours predict the ... traditional and enriched hatchery rearing environments. Based ...
(Date:10/27/2014)... have delivered a scientific one-two punch with a pair ... via their sticky ends. , Collagen is the most ... and the fibrous tissues that support cells and hold ... synthetic collagen for tissue engineering and cosmetic and reconstructive ... been studying synthetic collagen for a decade, teasing out ...
Breaking Biology News(10 mins):New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3Fish 'personality' linked to vulnerability to angling 2'Sticky' ends start synthetic collagen growth 2'Sticky' ends start synthetic collagen growth 3
... the subtext of a novel, the human genome sequence ... of A, C, T and G. Since DNA is ... genome sequences among individuals also holds clues to ancestry. ... sequence variations to diseases are very common nowadays. But ...
... - Discovery that a specific gene is integral to both ... toxin in the kernels may lead to ways to control ... the fungal gene ZFR1 and found that it is vital ... Production of the toxin decreased when the scientists disabled the ...
... 2008 -- Exposure to levels of radon gas typically found ... risk of developing lung cancer by as much as 60 ... issue of the journal Health Physics. The finding differs significantly ... of low-level radon exposure, which have detected a slightly elevated ...
Cached Biology News:Multi-institutional study identifies new form of inherited risk of cancer 2Defining gene's role may lead to prevention of dangerous corn toxin 2Defining gene's role may lead to prevention of dangerous corn toxin 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 2Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 3Exposure to low levels of radon appears to reduce the risk of lung cancer, new study finds 4
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
...
Bovine Serum...
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
Biology Products: